$CLSH “Innovative Marketing” Promoter Rank: 14/33 CLS Holdings USA, Inc. Newsletter 11:35:57 AM March 13, 2018

on March 13, 2018 Newsletters and Tags: , , , , , , , , , , with 0 comments

Overall Perfomance for "Innovative Marketing"

The following three charts can be used by potential investors to gauge the performance of "Innovative Marketing":


3 out of 14 campaigns closed down on first day


6 out of 14 campaigns closed up on first day


5 out of 14 campaigns had no net effect

CLSH Promotional Newsletter

The following is a newsletter released by "Innovative Marketing" promoting CLS Holdings USA, Inc.


The following newsletter has not been verified for accuracy or completeness.

March 13, 2018


Good Morning,

Our newest stock alert is Cannabis Life Sciences, you can get more information below and from their web site click on the logo.

CLSH also has an investor power point presentation that you can see here

CLS Holdings USA, Inc. OTCQB plans to become a diversified cannabis company and is shifting its corporate strategy to becoming a fully licensed integrated cannabis producer and retailer in Nevada and other western states. CLS stands for Cannabis Life Sciences, in recognition of the Companys patent pending proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. CLS also plans to specialize in the extraction and conversion of cannabinoids. The Companys business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.

CLS Holdings USA's Acquisition Target Oasis Cannabis Finalizes Plans to Expand Capacity

First Harvest Targeted for Early Q4 2018

LAS VEGAS, NV--Marketwired - March 13, 2018 - CLSHoldings USA, Inc. OTCQB CLSH CLS, a development stage diversified cannabis company operating as Cannabis LifeSciences, today announced that its planned acquisition target, Oasis Cannabis, has finalized construction plans for the initial expansion of its City Trees wholesale cultivation and production facility.

Construction is expected to commence within 30 days and completion is planned before the end of the second quarter. The facility will allow for harvests that are expected to yield approximately 150 pounds of premium cannabis flower and over 2,200 grams of distilled cannabis oil each month. Annual revenue from the facility is anticipated to exceed $15 million.

The first harvest is scheduled in early fourth quarter, but the company will immediately begin extracting cannabis oil internally upon completion of construction in June 2018.

Oasis Cannabis, Don Decatur, who is overseeing this project stated, We at City Trees are extremely excited about the start of this construction project. It will help us keep up with growing demands and will allow us to cut costs while also improving consistency and quality.

Oasis Cannabis is a fully integrated cannabis operation in Nevada. Las Vegas-based Oasis Cannabis' operations include a grow, extraction, conversion and processing facility and a retail dispensary. CLS has executed a definitive agreement to acquire the Oasis Cannabis companies. A non-refundable cash deposit has been paid by CLS. The closing of the transaction, which is subject to the satisfaction of a number of conditions, is expected to occur in the second quarter of 2018.

About Oasis Cannabis
Oasis Cannabis has operated a cannabis dispensary in the Las Vegas market since dispensaries first opened in Nevada in 2015 and has been recognized as one of the top marijuana retailers in the state. Its location within walking distance to the Las Vegas Strip and Downtown Las Vegas in combination with its delivery service to residents allows it to efficiently serve both locals and tourists in the Las Vegas area. The company recently commenced wholesale offerings of cannabis in Nevada with the launch of its City Trees brand of cannabis concentrates and cannabis-infused products in August 2017. An expansion of its cultivation and production facility is currently underway and is expected to be completed during the second half of 2018.

About CLS Holdings USA
CLS Holdings USA, Inc. OTCQB CLSH plans to become a diversified cannabis company and is shifting its corporate strategy to becoming a fully licensed integrated cannabis producer and retailer in Nevada and other states.

CLS stands for Cannabis Life Sciences, in recognition of the Company's patent pending proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.

For additional information, please visit

CLS has executed a definitive agreement to acquire the Oasis Cannabis companies from Alternative Solutions, LLC. The closing of the transaction is subject to the satisfaction of a number of conditions including our ability to raise cash, and as a result, there can be no assurance that we will be able to close the Oasis Acquisition. See CLS Holdings USA's filings with the SEC for additional details.

Forward Looking Statements
This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. These forward-looking statements include, but are not limited to, statements relating to whether certain transactions will be completed, the terms of such transactions, the descriptions of the companies and the business that any potential target companies could bring to CLS Holdings. In some cases, you can identify forward-looking statements by terminology such as may, might, will, should, intends, expects, plans, goals, projects, anticipates, believes, estimates, predicts, potential, or continue or the negative of these terms or other comparable terminology. These forward-looking statements are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. We cannot guarantee future results, levels of activity or performance and we cannot guaranty that the proposed transactions described in this press release will occur. You should not place undue reliance on these forward-looking statements, which speak only as of the date that they were made. These cautionary statements should be considered together with any written or oral forward-looking statements that we may issue in the future. Except as required by applicable law, we do not intend to update any of the forward-looking statements to conform these statements to reflect actual results, later events or circumstances or to reflect the occurrence of unanticipated events. CLS Holdings USA has entered into a definitive agreement to acquire Oasis Cannabis, which is expected to close in the second quarter of 2018. See CLS Holdings USA filing with the SEC for additional details.


This newsletter is owned by Innovative Marketing, This letter and website, its owners, their affiliates, directors, officers, employees and agents of the foregoing parties are hereafter collectively referred to as we, our or us.

We maintain control over the securities trading accounts in our name. We are often paid to publish information the Information about companies the Public Companies or Public Company or Issuer that are quoted on the OTC Markets or Pink Sheets. We are paid in either money or securities or both for our services. We are often paid for our advertisements by the Public Companies andor third parties, which may include shareholders of the Public Company. We are not independent and the information published by us is often a paid advertisement. We do not conduct research or evaluate if the Information is true or complete. We are not qualified to give you investment advice.

The Information should not be construed as a recommendation to purchase the securities of the Public Companies. We are not a an investment adviser b a stock picker c a securities trading expert d a securities analyst e a financial analyst or f one that i provides stock recommendations, ii price targets,iii provides buy recommendations, iv provides stock recommendations for assembling a portfolio of stocks from the information we provide, v represents that stocks are undervalued or iv provides advice about buy and or sell or hold recommendations as to specific securities moreover, any interpretation of the Information that we furnish should not be construed in that manner.

Third Party Websites This website or newsletter may provide hyperlinks to third party websites or access to third party content. Innovative Marketing, its owners, officers, directors, contractors and employees are not responsible for errors and omissions nor does Innovative Marketing control, endorse, or guarantee any content found in such sites. By accessing, viewing, or using the website or communications originating from this release, you agree that Innovative Marketing its owners, officers, directors, contractors and employees, are not responsible for any content, associated links, resources, or services associated with a third party website. You further agree that Innovative Marketing. its owners, officers, directors, contractors and employees shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only.

Our advertisements involve an actual conflict of interest, since we sometimes receive compensation in the very securities we are promoting and then sell the securities during our advertising campaign or advertorial activities or thereafter. The third party shareholder from which we receive compensation also has an actual conflict of interest since he or she pays us securities compensation for advertising services and then may sell other shares he or she holds, while we are promoting the issuer that issues the stock, held by the third party shareholder. A Public Company that pays us for our advertising services also has a conflict of interest since they are paying us compensation to advertise on their behalf, for their own benefit.

Innovative Marketing has been compensated $2500 from Cannabis Life Sciences, , Inc. . We have never owned any shares of CLSH stock.

The Public Companies we profile are considered penny stocks. Penny Stocks inherently involve high risk and volatility. You should be aware of the following information pertaining to penny stock investments and our activities

We conduct no due diligence whatsoever regarding a the Issuer b the third party shareholder and c the relationship, if any, between the third party shareholder and the Issuer

Our trading activities described above may cause a significant volatility in the Issuers stock price b price declines from our selling activities c unrealistic report of trading volume, without denoting publicly that we are the primary seller d permit us to make substantial profits while we are disseminating profiles or information about the issuer, yet may result in a diminished stock value for investors

We conduct no due diligence on the press releases or profiles we receive from OTC Markets News Service or other publicly available source, nor do we conduct due diligence on any other information we disseminate to the public

Penny stocks are subject to the SECs penny stock rules and subject broker-dealers to customer suitability rules and other requirements, which may lead to low volume in the securities andor difficulties in selling the shares

We do not assume any responsibility for forward looking statements nor do we assume any responsibility for updating forward looking statements

Use of this information is at your own risk and is presented only on an as is basis in other words, you must conduct your own analysis of the risks associated with use of the Information, including its accuracy or reliability

Many penny stocks are thinly traded, which may lead to difficulties in selling your securities and extreme price volatility Penny stock companies are often subject to extreme regulatory oversight in the industry that they participate in

Penny stock companies are often subject to extreme competition and most frequently have less brand name recognition, operational and personnel resources, technical resources, capital resources, or financing sources

There is no right time to purchase or sell penny stocks or set of factors making it advisable to purchase now, since at any time such stocks may be subject to price volatility, stock manipulation forces and other negative aspects

An issuer we profile may have negative signs on the otcmarkets.com website that indicate various risks of investing in that individual issuer, as follows i Limited Information for companies with financial reporting problems, economic distress, or that are unwilling to file required reports with the Pink Sheets ii Pink Sheets No Information, which indicates companies that are unable or unwilling to provide disclosure to the public markets, to the SEC or the Pink Sheets and iii Caveat Emptor, signifying Buyer Beware that there is a public interest concern associated with a companys illegal spam campaign, questionable stock promotion, known investigation of a companys fraudulent activity or its insiders, regulatory suspensions or disruptive corporate actions

The Issuer may be delinquent in its filings with the Securities and Exchange Commission or at otcmarkets.com, which you should determine at sec.gov or otcmarkets.com

The stock price and trading volume of any Issuer that we advertise may increase significantly as a result of our dissemination of the Information and then significantly decrease as a result of our or others selling significant or massive quantifies of an Issuers stock

Many penny stock companies are subject to risks pertaining to their type of business in their development stages, including that they have failed to provide a proof of concept to their technology or business or their business plan has little if no merit

Many penny stock companies are in need of financing, which they may be unable to obtain on favorable terms or at all

Our advertising activities may cause trading volume in Issuers to temporarily increase by hundreds or thousands of percent, yet such trading volume may cease at any one time, especially if we cease disseminating Information about the Issuers, which will cause difficulties in selling your securities or may be an unrealistic indicator of interest in the Issuers securities

The Information has no predictive value whatsoever of the future stock price of the Issuer that we profile or the Issuers ability to be successful in its business objectives

Should the SEC determine that inadequate information or irregularities have occurred with an Issuer, they may issue a trading suspension, which will suspend trading in the Issuers securities and may for all intents and purposes permanently cease trading because broker-dealers may not accept trades in that particular Issuers securities

The press releases, issuer profiles and information we provide represent only a small amount of information regarding the Issuer, which is insufficient to formulate an investment decision as such, that information should only be a starting point from which you conduct an in-depth investigation of the issuer from available public sources, such as , otcmarkets.com, and other available public sources and

You should conduct an in-depth investigation of the Issuer from the above or any other credible available sources, especially because we only present positive information and limited specific information which is an insufficient basis to invest in any stock, yet alone a penny stock accordingly, you should proceed with an investigation to determine, among other things, information pertaining to the issuers financial condition, operations, business model, and risks involved in the issuers business The compensation that we receive from Issuers appears at the link below. By clicking on the compensation link, and all links, you are acknowledging and agreeing that you will use this, and all information on this web site, in direct accordance with our privacy policy posted on our main page, and again here

If you no longer wish to receive these emails, please reply to this message with Unsubscribe in the subject line or simply click on the following link

Innovative Marketing
187 Wolf Road
Albany, NY 12205

the marketing policy.

Last 1 Stock Promotions By "Innovative Marketing"

Symbol Company Start Date Trades Open Close Change
CLSH CLS Holdings USA, Inc. October 3, 2017 0 0.365 0.365 0%